vimarsana.com

Page 2 - தேசிய ஆரோக்கியம் காப்பீடு ஆராய்ச்சி தரவுத்தளம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ACE Inhibitors/ARBs Appear On Par With Beta-blockers After Aortic Dissection

March 08, 2021 Over the long term, patients who survive an aortic dissection appear to do just as well treated with either beta-blockers or ACE inhibitors/ARBs rather than other antihypertensive drugs, a retrospective analysis suggests. Compared with other drug classes, beta-blockers and ACE inhibitors/ARBs each were associated with lower risks of all-cause hospital readmission and all-cause mortality over a span of up to 12 years, according to researchers led by Shao-Wei Chen, MD, PhD (Linkou Medical Center, Chang Gung University, Taoyuan City, Taiwan). There were no differences for any outcomes which also included death due to aortic aneurysm or dissection, later aortic operation, major adverse cardiac and cerebrovascular events, and new-onset dialysis when those two medication groups were compared with each other.

Association between metabolically healthy obesity/overweight and cardiovascular disease risk: A representative cohort study in Taiwan

Association between metabolically healthy obesity/overweight and cardiovascular disease risk: A representative cohort study in Taiwan Roles Data curation, Methodology, Validation Affiliations Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan, Department of Family Medicine, Taipei MacKay Memorial Hospital, Taipei, Taiwan ⨯ Ming-Chieh Tsai, Roles Methodology, Validation Affiliations Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan, Division of Endocrinology, Department of Internal Medicine, MacKay Memorial Hospital, Tamsui Branch, New Taipei City, Taiwan, Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan ⨯ Le-Yin Hsu, Affiliation Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.